secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0001829126-26-001911
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 3.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO launches AI infrastructure platform; licenses Researgency from Younet AI
--------------------------------------------------------------------------------

- Exclusive worldwide license to Researgency platform for biotech field; initial 12-month term with renewal options.
- Consideration includes up to $530k cash and issuance of 5 million shares of KALA common stock per term.
- Company holds an irrevocable option to acquire Younet AI for $55 million, exercisable during the term.
- Strategic pivot: KALA will deploy on-premises, data-sovereign AI for biotech clients targeting recurring revenue.
- KALA will first deploy on its own MSC-S and KPI-012 data; preliminary findings expected in 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626001911/0001829126-26-001911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626001911/kalabio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-001911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer